DCF — PARRISH MEDICAL CENTER
Enterprise Value: $-247.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-247.5M
Enterprise Value
$-77.9M
PV of Cash Flows
$-169.6M
PV of Terminal Value
$-273.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $142.9M | $-15.6M | -11.0% | $-21.7M | $-19.7M |
| Year 2 | $147.2M | $-14.6M | -10.0% | $-20.9M | $-17.2M |
| Year 3 | $151.6M | $-13.6M | -9.0% | $-20.0M | $-15.0M |
| Year 4 | $156.2M | $-13.2M | -8.0% | $-19.8M | $-13.5M |
| Year 5 | $160.9M | $-13.2M | -8.0% | $-20.0M | $-12.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-247.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$138.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11439808727125754
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5